+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Muscle Relaxant Drug Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129694
Global Muscle Relaxant Drug Market Size, Share & Trends Analysis Report by Product Type (Peripherally Acting Muscle Relaxants, Facial Aesthetic Relaxants, and Centrally Acting Muscle Relaxants), By Formulation (Oral and Injectable) Forecast, 2020-2026
The global muscle relaxant drug market is projected to grow significantly during the forecast period. The primary factors that are driving the growth of the global muscle relaxant drug industry include the increased number of geriatric populations who are more prone to musculoskeletal disorders which in turn enhances the adoption of muscle relaxant drugs and thereby fuel the market growth during the forecast period. Further, the rising prevalence of pain conditions in the peoples along with the availability of drugs is propelling the growth of the market during the forecast period. However, some side effects associated with the drugs may challenge the growth of the market.

The global muscle relaxant drug market is segmented on the basis of product type and formulation. Based on the product type, the global muscle relaxant drug industry is segmented into peripherally acting muscle relaxants, facial aesthetic relaxants, and centrally acting muscle relaxants. Peripherally acting muscle relaxants segment holds a significant share in the market over the forecast period. Based on the formulation, the market is bifurcated into oral and injectable. The oral segment is likely to hold the most significant share in the market.

Geographically, the study of the global muscle relaxant drug market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global muscle relaxant drug market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Further, AbbVie Inc., Acorda Therapeutics Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Mylan NV, Orient Pharma Co. Ltd., Par Pharmaceutical Inc., and Pfizer Inc. are some of the prominent players operating in the global muscle relaxant drug market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market.

Research Methodology

The market study of the global muscle relaxant drug market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for muscle relaxant drug market players, drug manufacturing companies, investment companies, industry associations & experts, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Muscle Relaxant Drug Market Research and Analysis by Type
2. Global Muscle Relaxant Drug Market Research and Analysis by Route of Administration

The Report covers:
  • Comprehensive research methodology of the global muscle relaxant drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global muscle relaxant drug market.
  • Insights about market determinants which are stimulating the global muscle relaxant drug market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Muscle Relaxant Drug Market by Product Type
5.1.1. Peripherally Acting Muscle Relaxants
5.1.2. Facial Aesthetic Relaxants
5.1.3. Centrally Acting Muscle Relaxants
5.2. Global Muscle Relaxant Drug Market by Formulation
5.2.1. Oral
5.2.2. Injectable
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Acorda Therapeutics Inc.
7.3. Aurobindo Pharma Ltd.
7.4. Cadila Healthcare Ltd.
7.5. DBL Pharma Inc.
7.6. Dr. Reddy's Laboratories Ltd.
7.7. Endo Pharmaceuticals Inc.
7.8. Ipsen Biopharmaceuticals Inc.
7.9. Johnson & Johnson Services Inc.
7.10. Merck & Co. Inc.
7.11. Mylan NV
7.12. Neurana Pharmaceuticals
7.13. Novartis International AG
7.14. Orient Pharma Co. Ltd.
7.15. Par Pharmaceutical Inc.
7.16. Pfizer Inc.
7.17. Vertical Pharmaceuticals LLC

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Aurobindo Pharma Ltd.
  • Cadila Healthcare Ltd.
  • DBL Pharma Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc.
  • Ipsen Biopharmaceuticals Inc.
  • Johnson & Johnson Services Inc.
  • Merck & Co. Inc.
  • Mylan NV
  • Neurana Pharmaceuticals
  • Novartis International AG
  • Orient Pharma Co. Ltd.
  • Par Pharmaceutical Inc.
  • Pfizer Inc.
  • Vertical Pharmaceuticals LLC